Skip to main content
Menu
US
US

Resource Center

Filters
Select resource types (1)
Select products & services
Select solutions (2)
Active Filters (3)
Clear All
1 - 12 of 32 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Whitepaper Icon   Whitepaper
Guidance for Ensuring Your VICTOR Nivo Multimode Plate Reader Complies with 21 CFR Part 11
With specific reference to the relevant paragraphs of 21 CFR Part 11, this document describes how the tools within the VICTOR Nivo Enhanced Security software facilitate compliance with this regulation.
Whitepaper Icon   Whitepaper
Guidance for ensuring your VICTOR Nivo multimode plate reader complies with 21 CFR Part 11
With specific reference to the relevant paragraphs of 21 CFR Part 11, this document describes how the tools within the VICTOR NivoTM Enhanced Security software facilitate compliance with this regulation.
Whitepaper Icon   Whitepaper
The importance of combination therapy for modern cancer treatments
This white paper discusses the importance of combination therapy for modern cancer treatments.
Whitepaper Icon   Whitepaper
Relevance of multiparametric screening to drug discovery efforts
This white paper explores the importance of multiparametric screening to drug discovery efforts
Whitepaper Icon   Whitepaper
Advancing biotherapeutic development with transposon-based technologies
Discover how to generate highly producing pools early on in your development workflow with transposon technology and accelerate time to clinic
Whitepaper Icon   Whitepaper
The evolving landscape of quality by design in biologics manufacturing
Implement QbD principles to meet safety, efficacy, and consistency challenges in biologics manufacturing
Whitepaper Icon   Whitepaper
Maximizing returns in biotherapeutic investment: Financial considerations for expression systems
Helping examine the key economic factors when selecting expression systems that impact quality, quantity, and cost-effectiveness for biotherapeutic production.
Whitepaper Icon   Whitepaper
Preclinical screening platforms for antibody-drug conjugate therapeutics
Learn more about ADCs and the role that screening can play to help advance the discovery process for ADC therapeutic candidates in this white paper.
Whitepaper Icon   Whitepaper
Sugar with your protein? - Generation of a fucosylation-deficient CHO cell host to produce therapeutics with enhanced potency
Detailed overview of how CHO cells have been genetically modified to enable production of afucosylated antibodies with enhanced ADCC activity for improved biotherapeutics
Whitepaper Icon   Whitepaper
Harnessing cell line engineering to enhance biotherapeutics
Exploring the next-generation genome editing tools that are helping drive the success of monoclonal antibodies as biotherapeutics
Whitepaper Icon   Whitepaper
Achieving higher throughput for the bioanalysis of advanced biotherapeutics
With advanced biotherapeutics requiring characterization and stringent quality control, read how by assessing critical quality attributes early within cell line development you can improve your chances in clinic
Whitepaper Icon   Whitepaper
EnVision Nexus & Kaleido Enhanced Security Software - Guide to 21 CFR Part 11 Compliance
For the EnVision Nexus™, our fastest, most sensitive plate reader, the Enhanced Security option is available as an add-on to the Kaleido™ software. It provides a variety of tools to guide you towards 21 CFR Part 11 compliance.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.